(+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of SGMS2 mRNA] CTD PMID:31150632 (1->4)-beta-D-glucan multiple interactions ISO RGD:1331987 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of SGMS2 mRNA CTD PMID:36331819 1,2-dimethylhydrazine decreases expression ISO RGD:1331987 6480464 1, 2-Dimethylhydrazine results in decreased expression of SGMS2 mRNA CTD PMID:22206623 2,3',4,4',5-Pentachlorobiphenyl decreases expression ISO RGD:1331987 6480464 2 more ... CTD PMID:31388691 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of SGMS2 mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1331987 6480464 Tetrachlorodibenzodioxin results in decreased expression of SGMS2 mRNA CTD PMID:27913140 more ... 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1605563 6480464 Tetrachlorodibenzodioxin results in increased expression of SGMS2 mRNA CTD PMID:23152189 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1331987 6480464 Tetrachlorodibenzodioxin affects the expression of SGMS2 mRNA CTD PMID:21570461 2-hydroxypropanoic acid increases expression ISO RGD:1605563 6480464 Lactic Acid results in increased expression of SGMS2 mRNA CTD PMID:30851411 3,3',5,5'-tetrabromobisphenol A increases expression ISO RGD:1331987 6480464 tetrabromobisphenol A results in increased expression of SGMS2 mRNA CTD PMID:25172293 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1605563 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of SGMS2 mRNA CTD PMID:28628672 4,4'-sulfonyldiphenol decreases methylation ISO RGD:1605563 6480464 bis(4-hydroxyphenyl)sulfone results in decreased methylation of SGMS2 gene CTD PMID:31601247 4,4'-sulfonyldiphenol increases methylation ISO RGD:1331987 6480464 bis(4-hydroxyphenyl)sulfone results in increased methylation of SGMS2 gene CTD PMID:31683443 4-hydroxyphenyl retinamide increases expression ISO RGD:1331987 6480464 Fenretinide results in increased expression of SGMS2 mRNA CTD PMID:28973697 acetamide decreases expression EXP 6480464 acetamide results in decreased expression of SGMS2 mRNA CTD PMID:31881176 acrylamide decreases expression ISO RGD:1331987 6480464 Acrylamide results in decreased expression of SGMS2 mRNA CTD PMID:35032568 aflatoxin B1 increases expression ISO RGD:1605563 6480464 Aflatoxin B1 results in increased expression of SGMS2 mRNA CTD PMID:22100608 aristolochic acid A decreases expression ISO RGD:1605563 6480464 aristolochic acid I results in decreased expression of SGMS2 mRNA CTD PMID:33212167 arsane multiple interactions ISO RGD:1605563 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of SGMS2 mRNA CTD PMID:32525701 arsenic atom multiple interactions ISO RGD:1605563 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of SGMS2 mRNA CTD PMID:32525701 benzo[a]pyrene decreases expression ISO RGD:1331987 6480464 Benzo(a)pyrene results in decreased expression of SGMS2 mRNA CTD PMID:19770486 benzo[a]pyrene decreases methylation ISO RGD:1605563 6480464 Benzo(a)pyrene results in decreased methylation of SGMS2 promoter CTD PMID:27901495 benzo[a]pyrene increases methylation ISO RGD:1605563 6480464 Benzo(a)pyrene results in increased methylation of SGMS2 5' UTR CTD PMID:27901495 benzo[a]pyrene decreases methylation ISO RGD:1331987 6480464 Benzo(a)pyrene results in decreased methylation of SGMS2 3' UTR more ... CTD PMID:27901495 benzo[a]pyrene increases expression ISO RGD:1331987 6480464 Benzo(a)pyrene results in increased expression of SGMS2 mRNA CTD PMID:27195522 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:1605563 6480464 7 more ... CTD PMID:19150397 Benzo[ghi]perylene increases expression ISO RGD:1331987 6480464 1, 12-benzoperylene results in increased expression of SGMS2 mRNA CTD PMID:26377693 bis(2-ethylhexyl) phthalate increases expression ISO RGD:1605563 6480464 Diethylhexyl Phthalate results in increased expression of SGMS2 mRNA CTD PMID:31163220 bisphenol A decreases expression ISO RGD:1605563 6480464 bisphenol A results in decreased expression of SGMS2 mRNA CTD PMID:33476716 bisphenol A decreases methylation ISO RGD:1605563 6480464 bisphenol A results in decreased methylation of SGMS2 gene CTD PMID:31601247 bisphenol A multiple interactions ISO RGD:1605563 6480464 [bisphenol A co-treated with Fulvestrant] results in decreased methylation of SGMS2 gene, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of SGMS2 mRNA CTD PMID:28628672 , PMID:31601247 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of SGMS2 gene CTD PMID:28505145 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of SGMS2 mRNA CTD PMID:25181051 bisphenol A affects expression ISO RGD:1331987 6480464 bisphenol A affects the expression of SGMS2 mRNA CTD PMID:26063408 cadmium atom multiple interactions ISO RGD:1605563 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SGMS2 mRNA CTD PMID:35301059 cadmium dichloride multiple interactions ISO RGD:1605563 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SGMS2 mRNA CTD PMID:35301059 carbon nanotube increases expression ISO RGD:1331987 6480464 Nanotubes more ... CTD PMID:25554681 carbon nanotube decreases expression ISO RGD:1331987 6480464 Nanotubes, Carbon results in decreased expression of SGMS2 mRNA CTD PMID:25620056 chlorpyrifos increases methylation EXP 6480464 Chlorpyrifos results in increased methylation of SGMS2 gene CTD PMID:32905263 chromium(6+) affects expression ISO RGD:1331987 6480464 chromium hexavalent ion affects the expression of SGMS2 mRNA CTD PMID:28472532 cisplatin increases expression ISO RGD:1605563 6480464 Cisplatin results in increased expression of SGMS2 mRNA CTD PMID:27594783 cisplatin decreases expression ISO RGD:1605563 6480464 Cisplatin results in decreased expression of SGMS2 mRNA CTD PMID:27392435 cisplatin multiple interactions ISO RGD:1605563 6480464 [Cisplatin co-treated with jinfukang] results in decreased expression of SGMS2 mRNA CTD PMID:27392435 cobalt dichloride increases expression EXP 6480464 cobaltous chloride results in increased expression of SGMS2 mRNA CTD PMID:24386269 copper(II) sulfate affects expression ISO RGD:1605563 6480464 Copper Sulfate affects the expression of SGMS2 mRNA CTD PMID:19549813 crocidolite asbestos increases expression ISO RGD:1605563 6480464 Asbestos, Crocidolite results in increased expression of SGMS2 mRNA CTD PMID:18687144 cyclosporin A increases expression ISO RGD:1331987 6480464 Cyclosporine results in increased expression of SGMS2 mRNA CTD PMID:19770486 cyclosporin A increases expression ISO RGD:1605563 6480464 Cyclosporine results in increased expression of SGMS2 mRNA CTD PMID:20106945 more ... dexamethasone multiple interactions ISO RGD:1605563 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of SGMS2 mRNA CTD PMID:28628672 dextran sulfate increases expression ISO RGD:1331987 6480464 Dextran Sulfate results in increased expression of SGMS2 mRNA CTD PMID:25035112 dicrotophos decreases expression ISO RGD:1605563 6480464 dicrotophos results in decreased expression of SGMS2 mRNA CTD PMID:28302478 dioxygen multiple interactions ISO RGD:1331987 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SGMS2 mRNA CTD PMID:30529165 dioxygen multiple interactions EXP 6480464 [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] affects the expression of SGMS2 mRNA CTD PMID:33729688 dorsomorphin multiple interactions ISO RGD:1605563 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 entinostat increases expression ISO RGD:1605563 6480464 entinostat results in increased expression of SGMS2 mRNA CTD PMID:27188386 ethyl methanesulfonate decreases expression ISO RGD:1605563 6480464 Ethyl Methanesulfonate results in decreased expression of SGMS2 mRNA CTD PMID:23649840 fenamidone increases expression ISO RGD:1331987 6480464 fenamidone results in increased expression of SGMS2 mRNA CTD PMID:27029645 formaldehyde decreases expression ISO RGD:1605563 6480464 Formaldehyde results in decreased expression of SGMS2 mRNA CTD PMID:20655997 fulvestrant multiple interactions ISO RGD:1605563 6480464 [bisphenol A co-treated with Fulvestrant] results in decreased methylation of SGMS2 gene CTD PMID:31601247 geldanamycin increases expression ISO RGD:1605563 6480464 geldanamycin results in increased expression of SGMS2 mRNA CTD PMID:26705709 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of SGMS2 mRNA CTD PMID:33387578 glycidol decreases expression EXP 6480464 glycidol results in decreased expression of SGMS2 mRNA CTD PMID:24395379 indometacin multiple interactions ISO RGD:1605563 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of SGMS2 mRNA CTD PMID:28628672 inulin multiple interactions ISO RGD:1331987 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of SGMS2 mRNA CTD PMID:36331819 lipopolysaccharide multiple interactions ISO RGD:1605563 6480464 [S-(1, 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of SGMS2 mRNA CTD PMID:35811015 manganese(II) chloride increases expression EXP 6480464 manganese chloride results in increased expression of SGMS2 mRNA CTD PMID:28801915 methyl methanesulfonate decreases expression ISO RGD:1605563 6480464 Methyl Methanesulfonate results in decreased expression of SGMS2 mRNA CTD PMID:23649840 methylisothiazolinone increases expression ISO RGD:1605563 6480464 2-methyl-4-isothiazolin-3-one results in increased expression of SGMS2 mRNA CTD PMID:31629900 methylmercury chloride decreases expression ISO RGD:1605563 6480464 methylmercuric chloride results in decreased expression of SGMS2 mRNA CTD PMID:28001369 methylparaben decreases expression ISO RGD:1605563 6480464 methylparaben results in decreased expression of SGMS2 mRNA CTD PMID:31745603 N-methyl-4-phenylpyridinium increases expression EXP 6480464 1-Methyl-4-phenylpyridinium results in increased expression of SGMS2 mRNA CTD PMID:28801915 nickel atom increases expression ISO RGD:1605563 6480464 Nickel results in increased expression of SGMS2 mRNA CTD PMID:24768652 , PMID:25583101 nickel sulfate decreases expression ISO RGD:1605563 6480464 nickel sulfate results in decreased expression of SGMS2 mRNA CTD PMID:22714537 paracetamol affects expression ISO RGD:1331987 6480464 Acetaminophen affects the expression of SGMS2 mRNA CTD PMID:17562736 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of SGMS2 mRNA CTD PMID:33387578 paracetamol increases expression ISO RGD:1605563 6480464 Acetaminophen results in increased expression of SGMS2 mRNA CTD PMID:21420995 paraquat increases expression EXP 6480464 Paraquat results in increased expression of SGMS2 mRNA CTD PMID:32680482 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:1331987 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of SGMS2 mRNA, [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of SGMS2 mRNA CTD PMID:36331819 phenobarbital affects expression ISO RGD:1331987 6480464 Phenobarbital affects the expression of SGMS2 mRNA CTD PMID:23091169 pirinixic acid multiple interactions ISO RGD:1605563 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of SGMS2 mRNA CTD PMID:19710929 pirinixic acid multiple interactions ISO RGD:1331987 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of SGMS2 mRNA CTD PMID:19710929 rac-lactic acid increases expression ISO RGD:1605563 6480464 Lactic Acid results in increased expression of SGMS2 mRNA CTD PMID:30851411 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:1605563 6480464 [S-(1, 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of SGMS2 mRNA CTD PMID:35811015 S-(1,2-dichlorovinyl)-L-cysteine decreases expression ISO RGD:1605563 6480464 S-(1, 2-dichlorovinyl)cysteine results in decreased expression of SGMS2 mRNA CTD PMID:35811015 SB 431542 multiple interactions ISO RGD:1605563 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 silver atom increases expression ISO RGD:1605563 6480464 Silver results in increased expression of SGMS2 mRNA CTD PMID:26014281 silver(0) increases expression ISO RGD:1605563 6480464 Silver results in increased expression of SGMS2 mRNA CTD PMID:26014281 sodium arsenate multiple interactions ISO RGD:1605563 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of SGMS2 mRNA CTD PMID:32525701 sodium dodecyl sulfate increases expression ISO RGD:1605563 6480464 Sodium Dodecyl Sulfate results in increased expression of SGMS2 mRNA CTD PMID:31734321 sulforaphane increases expression ISO RGD:1605563 6480464 sulforaphane results in increased expression of SGMS2 mRNA CTD PMID:26833863 sunitinib decreases expression ISO RGD:1605563 6480464 Sunitinib results in decreased expression of SGMS2 mRNA CTD PMID:31533062 testosterone decreases expression ISO RGD:1331987 6480464 Testosterone deficiency results in decreased expression of SGMS2 mRNA CTD PMID:33848595 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of SGMS2 mRNA CTD PMID:31150632 tetrachloromethane increases expression ISO RGD:1331987 6480464 Carbon Tetrachloride results in increased expression of SGMS2 mRNA CTD PMID:31919559 tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of SGMS2 mRNA] CTD PMID:31150632 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of SGMS2 mRNA CTD PMID:23411599 , PMID:34492290 trichloroethene increases methylation EXP 6480464 Trichloroethylene results in increased methylation of SGMS2 gene CTD PMID:27618143 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of SGMS2 mRNA CTD PMID:33387578 trichostatin A decreases expression ISO RGD:1605563 6480464 trichostatin A results in decreased expression of SGMS2 mRNA CTD PMID:24935251 trichostatin A multiple interactions ISO RGD:1605563 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SGMS2 mRNA CTD PMID:27188386 trichostatin A increases expression ISO RGD:1605563 6480464 trichostatin A results in increased expression of SGMS2 mRNA CTD PMID:24935251 , PMID:26272509 triclosan increases expression ISO RGD:1605563 6480464 Triclosan results in increased expression of SGMS2 mRNA CTD PMID:30510588 triptonide increases expression ISO RGD:1331987 6480464 triptonide results in increased expression of SGMS2 mRNA CTD PMID:33045310 urethane increases expression ISO RGD:1605563 6480464 Urethane results in increased expression of SGMS2 mRNA CTD PMID:28818685 valproic acid affects expression ISO RGD:1331987 6480464 Valproic Acid affects the expression of SGMS2 mRNA CTD PMID:17292431 valproic acid multiple interactions ISO RGD:1605563 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SGMS2 mRNA CTD PMID:27188386 valproic acid increases expression ISO RGD:1605563 6480464 Valproic Acid results in increased expression of SGMS2 mRNA CTD PMID:23179753 more ... valproic acid decreases expression ISO RGD:1605563 6480464 Valproic Acid results in decreased expression of SGMS2 mRNA CTD PMID:24935251 valproic acid affects expression ISO RGD:1605563 6480464 Valproic Acid affects the expression of SGMS2 mRNA CTD PMID:25979313 vinclozolin increases methylation EXP 6480464 vinclozolin results in increased methylation of SGMS2 gene CTD PMID:31682807 zinc atom multiple interactions ISO RGD:1605563 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of SGMS2 mRNA CTD PMID:18593933 zinc(0) multiple interactions ISO RGD:1605563 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of SGMS2 mRNA CTD PMID:18593933